LADOGA

A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)

OleclumabOngoingActive not recruitingPhase 2Open NCT06606847 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

LADOGA · Trial Tracker · ComplyRx